Transamerica Financial Advisors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-1
Closed -$1K – 701
2023
Q4
$1K Hold
1
– – ﹤0.01% 621
2023
Q3
$1K Hold
1
– – ﹤0.01% 642
2023
Q2
$1K Buy
+1
New +$41 ﹤0.01% 614
2023
Q1
– Sell
-1
Closed -$1K – 717
2022
Q4
$1K Hold
1
– – ﹤0.01% 686
2022
Q3
$1K Hold
1
– – ﹤0.01% 641
2022
Q2
$1K Buy
+1
New +$42 ﹤0.01% 652
2020
Q3
– Sell
-1
Closed -$1K – 513
2020
Q2
$1K Buy
+1
New +$41 ﹤0.01% 501
2019
Q3
– Sell
-1
Closed -$1K – 549
2019
Q2
$1K Buy
+1
New +$39 ﹤0.01% 546
2019
Q1
– Sell
-1
Closed -$1K – 483
2018
Q4
$1K Hold
1
– – ﹤0.01% 496
2018
Q3
$1K Hold
1
– – ﹤0.01% 493
2018
Q2
$1K Hold
1
– – ﹤0.01% 483
2018
Q1
$1K Hold
1
– – ﹤0.01% 439
2017
Q4
$1K Hold
1
– – ﹤0.01% 416
2017
Q3
$1K Hold
1
– – ﹤0.01% 406
2017
Q2
$1K Hold
1
– – ﹤0.01% 383
2017
Q1
$1K Hold
1
– – ﹤0.01% 375
2016
Q4
$1K Buy
+1
New +$41 ﹤0.01% 410
2015
Q3
– Sell
-2
Closed -$1K – 926
2015
Q2
$1K Hold
2
– – ﹤0.01% 868
2015
Q1
$1K Hold
2
– – ﹤0.01% 867
2014
Q4
$1K Hold
2
– – ﹤0.01% 708
2014
Q3
$1K Hold
2
– – ﹤0.01% 663
2014
Q2
$1K Hold
2
– – ﹤0.01% 672
2014
Q1
$1K Buy
+2
New +$94 ﹤0.01% 632

Other funds holding XPH

Transamerica Financial Advisors's XPH Position: Q1 2024 in Review

Transamerica Financial Advisors sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2024, closing a stake of 1 share — an estimated $1K sold.

Transamerica Financial Advisors first reported a position in XPH in Q1 2014 and held it in 23 quarters. The position peaked at $1K in Q4 2023. 73 funds tracked by Wall St. Rank hold XPH as of Q1 2024.

  • Transamerica Financial Advisors reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2024 after selling out during the quarter.
  • Transamerica Financial Advisors sold 1 State Street SPDR S&P Pharmaceuticals ETF share in Q1 2024, an estimated $1K.
  • Transamerica Financial Advisors first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2014 and held it in 23 quarters.
  • Transamerica Financial Advisors's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1K in Q4 2023.
  • 73 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2024.

Based on Transamerica Financial Advisors's 13F filing for Q1 2024, filed 15 May 2024.